Home/Filings/4/0001654954-22-001174
4//SEC Filing

Mazar Andrew Paul 4

Accession 0001654954-22-001174

CIK 0001645469other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 7:38 PM ET

Size

7.4 KB

Accession

0001654954-22-001174

Insider Transaction Report

Form 4
Period: 2022-02-02
Transactions
  • Award

    Stock Options

    2022-02-02+88,87488,874 total
    Exercise: $2.80Exp: 2032-02-01Common Stock (88,874 underlying)
  • Award

    Restricted Stock Units

    2022-02-02+67,25190,398 total
    Exercise: $0.00Common Stock (67,251 underlying)
Footnotes (2)
  • [F1]Options vest 6/48ths on June 30, 2022 and 1/48ths per month thereafter.
  • [F2]RSUs vest 6/48ths on June 30, 2022 and 3/48ths per quarter thereafter (September 30, 2022, December 31, 2022, March 31, 2023, June 30, 2023, September 30, 2023, December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025, December 31, 2025)

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1
  • filerCIK 0001727393

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:38 PM ET
Size
7.4 KB